www.naturewell.com/Products/MigraSpray.aspx
MigraSpray is a patented, clinically tested, over-the-counter homeopathic drug that is indicated as a comprehensive approach for the treatment and prevention of migraine headaches (MigraSpray can also be effective for treating the pain and symptoms associated with menstrual cycles as well as tension headaches and hangovers). Use it for the rapid treatment of a migraine attack or use it daily to dramatically reduce or eliminate the onset of migraine symptoms. MigraSpray is currently sold through select healthcare practitioners and independent pharmacies throughout the United States, as well as directly to consumers over the Internet and by telephone.
MigraSpray contains only natural, standardized ingredients and there have been no reported side effects and no reports of interaction with any over-the-counter or prescription medications. MigraSpray is safe for treating migraine attacks and safe for regular daily use to prevent the onset of migraine headache symptoms. There have been no reports of Medication Overuse Headache (MOH).
MigraSpray contains the active ingredients feverfew (its primary ingredient) polyporus, goldenseal and dandelion. Feverfew has been used for centuries for the treatment of a variety of ailments including headaches, rheumatic aches, abdominal pain and menstrual cramps. Studies have shown that feverfew acts as a natural anti-inflammatory controlling the inflammation that results in cerebral blood vessel dilation, believed to cause or contribute to the symptoms of migraine headaches. The active ingredients in feverfew are sesquiterpene lactones, the primary component being Parthenolide, a phytochemical.
In limited doctor tests conducted on behalf of the Company, and consistent with large clinical studies indicating the effectiveness of feverfew for preventing migraines, MigraSpray has been shown to be effective in dramatically reducing the frequency and severity of migraine headaches, even eliminating them entirely, when taken daily. MigraSpray has also been clinically shown to provide 88% of patients relief from an acute migraine attack in less than 7 minutes.
MigraSpray is administered under the tongue (sublingual), which allows the rapid introduction of ingredients into the bloodstream via the blood vessels located in the highly vascularized mucous membrane. This route of absorption bypasses the gastro-intestinal tract and requires only small dosages of the active ingredients contained in MigraSpray, which reduces risk of side effects and enhances efficacy. Furthermore, the administration of sublingual drugs offers improved drug bioavailability and rapid metabolization allowing more complete absorption and maximizing the benefit to the patient by permitting more precise dosage control.
